MedTrace Logo

Time for a Paradigm Shift: STEMI/NSTEMI to OMI/NOMI ?

NCT05705102 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2024-08-27

No results posted yet for this study

Summary

The current ST-segment elevation (STEMI)/non-STEMI treatment paradigm misses nearly one fourth of acute coronary occlusions (ACO) that needs immediately reperfusion. Many of these cases can be recognized by subtle changes on ECG, but the current STEMI criteria do not include them. The investigators of this research believe a new occlusive/non-occlusive myocardial infarction (OMI/NOMI) approach will be superior to the established STEMI/non-STEMI paradigm in early detection of ACO, limiting infarct size, reducing re-hospitalizations and most important of all, reducing mortality.

Conditions

Interventions

OTHER

Coronary intervention

Coronary intervention will be done immediately in patients with OMI (even STEMI criteria are negative), instead of waiting for \<24h.

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Emre Aslanger · Marmara University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2022-09-01
Completion
2024-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05705102 on ClinicalTrials.gov